Showing all posts written by Rebecca Wright
Rebecca Wright earned her J.D. at George Washington University and her Ph.D. in Biochemistry Molecular Biology at the University of California Davis. Rebecca's graduate work involved ascertaining the role of DNA translocations in the formation of leukemia. While at George Washington University, Rebecca worked on the American Intellectual Property Law Association Journal.
Positive Clinical Results for Using Myriad’s BRACAnalysis CDx® for Identifying Breast Cancer Patients for Treatment with Lynaparza
Myriad Genetics recently announced clinical results showing that its BRACAnalysis CDx® test was able to identify patients with HER2-negative metastatic breast cancer who had improved response with Lynparza (olaparib), AstraZeneca’s